Literature DB >> 4206027

Pseudomonas aeruginosa exotoxin in mice: localization and effect on protein synthesis.

O R Pavlovskis, A H Shackelford.   

Abstract

We studied the fate of (125)I-labeled Pseudomonas aeruginosa (PA 103) exotoxin injected intravenously into mice and the effect of the exotoxin on the protein synthesis of various organs. After 2 h, only 5% of the injected label remained in the blood, in comparison with 30% of the injected control, consisting of [(125)I]bovine serum albumin. The highest concentration of radioactivity was consistently observed in the kidneys of toxin-treated mice. Lesser amounts of the label were found in the liver and the spleen. The heart, pancreas, lung, and brain showed very little uptake. Approximately 30% of the label (non-trichloroacetic acid precipitable) was recovered from the urine within 2 h after the injection. The behavior of [(125)I]toxoid was similar to that of the [(125)I]toxin. In contrast, in [(125)I]bovine serum albumin-treated mice, the label was uniformly distributed among the organs examined, and the concentration was low. After intravenous administration of the exotoxin, a 50% inhibition of protein synthesis was observed in the liver within 4 h, and virtually complete inhibition was observed shortly before the time of death. Kidney and spleen displayed slight reduction of protein synthesis at 2 to 4 h and approximately 50% reduction during the terminal stage. It appeared that the highest concentration of the toxin occurred in the kidney, where it was degraded, but its greatest toxic effect took place in the liver.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4206027      PMCID: PMC414841          DOI: 10.1128/iai.9.3.540-546.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  TOXICITY OF PSEUDOMONAS AERUGINOSA SLIME.

Authors:  W S CALLAHAN; B BEYERLEIN; J D MULL
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

2.  Pseudomonas exotoxin shock. A preliminary report of studies in dogs.

Authors:  M Atik; P V Liu; B A Hanson; S Amini; C F Rosenberg
Journal:  JAMA       Date:  1968-07-15       Impact factor: 56.272

3.  The lethal events in experimental Pseudomonas aeruginosa infection of mice.

Authors:  P F Bartell; T E Orr; M Garcia
Journal:  J Infect Dis       Date:  1968-04       Impact factor: 5.226

4.  Characterization of a plasma kinin-inactivating enzyme produced by Pseudomonas aeruginosa.

Authors:  H E Rugstad
Journal:  Br J Pharmacol Chemother       Date:  1967-06

5.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

6.  Purification and characterization of Pseudomonas aeruginosa exotoxin.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

7.  In vivo studies with a toxic fraction of Pseudomonas aeruginosa.

Authors:  G Meinke; R S Berk
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

8.  Vascular permeability factor of Pseudomonas aeruginosa.

Authors:  H Kusama; R H Suss
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

9.  PARTIAL PURIFICATION OF THE EXTRACELLULAR HEMOLYSIN OF PSEUDOMONAS AERUGINOSA.

Authors:  R S BERK
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

10.  Studies on the mode of action of diphtheria toxin. III. Effect on subcellular components of protein synthesis from the tissues of intoxicated guinea pigs and rats.

Authors:  C G Bowman; P F Bonventre
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

View more
  23 in total

1.  Growth of Pseudomonas aeruginosa in normal and burned skin extract: role of extracellular proteases.

Authors:  J F Cicmanec; I A Holder
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

2.  NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,.

Authors:  B H Iglewski; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

3.  Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography.

Authors:  N S Taylor; M Pollack
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

4.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa.

Authors:  R M Berka; G L Gray; M L Vasil
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa.

Authors:  D W Chung; R J Collier
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

7.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2.

Authors:  O R Pavlovskis; B H Iglewski; M Pollack
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

10.  Exotoxin production by clinical isolates of pseudomonas aeruginosa.

Authors:  M Pollack; N S Taylor; L T Callahan
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.